bioAffinity Technologies, Inc. (BIAF)

bioAffinity Technologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-8.45	-7.94	-8.15	-6.33	-7.27
Depreciation & Amortization	0.73	0.38	0.01	0	0.02
Other Amortization	-	-	2.06	0.48	-
Stock-Based Compensation	0.99	0.75	0.25	0.04	0.28
Other Operating Activities	-0.13	-0.13	1.65	3.12	4.28
Change in Accounts Receivable	-0.28	0.31	-0.01	-	-
Change in Inventory	-0.02	-0.01	-0.01	-	-
Change in Accounts Payable	-0.24	-0.01	0.11	0.04	0.09
Change in Unearned Revenue	-0.01	0.03	-	-	-
Change in Other Net Operating Assets	0.2	0.58	0.01	0.59	0.39
Operating Cash Flow	-7.2	-6.04	-4.07	-2.05	-2.21
Capital Expenditures	-0.07	-0.02	-0.22	-	-0
Cash Acquisitions	-	-2.19	-	-	-
Investing Cash Flow	-0.07	-2.21	-0.22	-	-0
Short-Term Debt Issued	-	-	0.72	3.3	1.48
Long-Term Debt Issued	-	-	0.56	0.21	0.24
Total Debt Issued	0.29	-	1.28	3.51	1.72
Long-Term Debt Repaid	-	-0.34	-0.69	-	-
Net Debt Issued (Repaid)	-0.07	-0.34	0.58	3.51	1.72
Issuance of Common Stock	3.58	-	13.82	-	-
Repurchase of Common Stock	-	-	-0	-	-
Other Financing Activities	-	-	-0.06	-0.18	-
Financing Cash Flow	3.52	-0.34	14.34	3.33	1.72
Net Cash Flow	-3.75	-8.59	10.05	1.28	-0.5
Free Cash Flow	-7.27	-6.06	-4.29	-2.05	-2.21
Free Cash Flow Margin	-77.60%	-239.32%	-89336.50%	-	-
Free Cash Flow Per Share	-0.68	-0.69	-0.95	-0.77	-0.83
Cash Interest Paid	0.04	0.04	0.03	-	-
Cash Income Tax Paid	0.01	0.02	0	0	0
Levered Free Cash Flow	-3.71	-3.61	-3.41	-0.85	-
Unlevered Free Cash Flow	-3.65	-3.58	-3.89	-0.71	-
Change in Net Working Capital	0.09	-0.3	1.42	-0.63	-

Source: S&P Capital IQ. Standard template. Financial Sources.